DK344488D0 - Hexacycliske forbindelser - Google Patents
Hexacycliske forbindelserInfo
- Publication number
- DK344488D0 DK344488D0 DK344488A DK344488A DK344488D0 DK 344488 D0 DK344488 D0 DK 344488D0 DK 344488 A DK344488 A DK 344488A DK 344488 A DK344488 A DK 344488A DK 344488 D0 DK344488 D0 DK 344488D0
- Authority
- DK
- Denmark
- Prior art keywords
- compound
- hexacyclic compounds
- antitumour
- camptothecin
- chem
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- -1 aminoketone compound Chemical class 0.000 abstract 2
- 230000000259 anti-tumor effect Effects 0.000 abstract 2
- 238000006928 Friedlaender synthesis reaction Methods 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- VSJKWCGYPAHWDS-FQEVSTJZSA-N camptothecin Chemical class C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-FQEVSTJZSA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D515/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Luminescent Compositions (AREA)
- Lubricants (AREA)
- Fats And Perfumes (AREA)
- Liquid Crystal Substances (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP15699087 | 1987-06-24 | ||
| JP550388 | 1988-01-13 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK344488D0 true DK344488D0 (da) | 1988-06-23 |
| DK344488A DK344488A (da) | 1989-02-24 |
Family
ID=26339454
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK344488A DK344488A (da) | 1987-06-24 | 1988-06-23 | Hexacycliske forbindelser |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US4939255A (da) |
| EP (1) | EP0296597B1 (da) |
| KR (1) | KR960002853B1 (da) |
| AT (1) | ATE111913T1 (da) |
| AU (1) | AU610189B2 (da) |
| CA (1) | CA1304370C (da) |
| DE (1) | DE3851577T2 (da) |
| DK (1) | DK344488A (da) |
| ES (1) | ES2064329T3 (da) |
| FI (1) | FI91872C (da) |
| IE (1) | IE61281B1 (da) |
| NO (1) | NO167738C (da) |
| PH (1) | PH27557A (da) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4939255A (en) * | 1987-06-24 | 1990-07-03 | Daiichi Pharmaceutical Co., Ltd. | Hexa-cyclic camptothecin derivatives |
| US5552154A (en) * | 1989-11-06 | 1996-09-03 | The Stehlin Foundation For Cancer Research | Method for treating cancer with water-insoluble s-camptothecin of the closed lactone ring form and derivatives thereof |
| JP3008226B2 (ja) * | 1991-01-16 | 2000-02-14 | 第一製薬株式会社 | 六環性化合物 |
| US6407115B1 (en) * | 1991-01-16 | 2002-06-18 | Daiichi Pharmaceutical Co., Ltd. | Hexa-cyclic compound |
| US5637770A (en) * | 1991-01-16 | 1997-06-10 | Daiichi Pharmaceutical Co., Ltd. | Hexa-cyclic compound |
| US6080751A (en) * | 1992-01-14 | 2000-06-27 | The Stehlin Foundation For Cancer Research | Method for treating pancreatic cancer in humans with water-insoluble S-camptothecin of the closed lactone ring form and derivatives thereof |
| US5446047A (en) * | 1992-07-23 | 1995-08-29 | Sloan-Kettering Institute For Cancer Research | Camptothecin analogues |
| US5391745A (en) * | 1992-07-23 | 1995-02-21 | Sloan-Kettering Institute For Cancer Research | Methods of preparation of camptothecin analogs |
| US6504029B1 (en) * | 1995-04-10 | 2003-01-07 | Daiichi Pharmaceutical Co., Ltd. | Condensed-hexacyclic compounds and a process therefor |
| US5663177A (en) * | 1995-05-31 | 1997-09-02 | Smithkline Beecham Corporation | Water soluble camptothecin analogs |
| US5670500A (en) * | 1995-05-31 | 1997-09-23 | Smithkline Beecham Corporation | Water soluble camptothecin analogs |
| US5942386A (en) * | 1995-06-07 | 1999-08-24 | Thomas Jefferson University | Anti-fungal agents and methods of identifying and using the same |
| SG50747A1 (en) * | 1995-08-02 | 1998-07-20 | Tanabe Seiyaku Co | Comptothecin derivatives |
| SG104284A1 (en) * | 1996-10-30 | 2004-06-21 | Tanabe Seiyaku Co | S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof |
| KR19980076076A (ko) * | 1997-04-04 | 1998-11-16 | 유현식 | 전선용 발포성 수지조성물 |
| US6046209A (en) * | 1997-05-27 | 2000-04-04 | Smithkline Beecham Corporation | Water soluble camptothecin analogs |
| IN189180B (da) * | 1997-07-09 | 2003-01-04 | Chong Kun Dang Corp | |
| JP4094710B2 (ja) | 1997-11-06 | 2008-06-04 | 株式会社ヤクルト本社 | 新規なカンプトテシン誘導体 |
| EP1229934B1 (en) | 1999-10-01 | 2014-03-05 | Immunogen, Inc. | Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| FR2801309B1 (fr) * | 1999-11-18 | 2002-01-04 | Adir | Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| HUP0500062A3 (en) | 2001-11-30 | 2012-12-28 | Chugai Pharmaceutical Co Ltd | Fused camptothecin derivatives, process for their preparation and pharmaceutical compositions thereof |
| US8034831B2 (en) | 2002-11-06 | 2011-10-11 | Celgene Corporation | Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies |
| US7563810B2 (en) | 2002-11-06 | 2009-07-21 | Celgene Corporation | Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases |
| CN1777611A (zh) | 2003-02-21 | 2006-05-24 | 中外制药株式会社 | 制备六环喜树碱衍生物的方法 |
| CA2563502A1 (en) | 2004-04-09 | 2005-10-20 | Chugai Seiyaku Kabushiki Kaisha | Novel water-soluble prodrug |
| TW200744603A (en) | 2005-08-22 | 2007-12-16 | Chugai Pharmaceutical Co Ltd | Novel anticancer concomitant drug |
| CN102060713A (zh) * | 2010-12-09 | 2011-05-18 | 中华人民共和国嘉兴出入境检验检疫局 | 用于检测偶氮类染料的芳香胺半抗原及其制备方法 |
| KR102679892B1 (ko) | 2019-03-29 | 2024-07-02 | 메디뮨 리미티드 | 화합물 및 이의 접합체 |
| TW202140076A (zh) | 2020-01-22 | 2021-11-01 | 英商梅迪繆思有限公司 | 化合物及其軛合物 |
| WO2021148500A1 (en) | 2020-01-22 | 2021-07-29 | Medimmune Limited | Compounds and conjugates thereof |
| US11806405B1 (en) | 2021-07-19 | 2023-11-07 | Zeno Management, Inc. | Immunoconjugates and methods |
| JP2025510700A (ja) | 2022-03-23 | 2025-04-15 | シンアフィックス ビー．ブイ． | Ｔｒｏｐ－２を発現する腫瘍を標的化するための抗体コンジュゲート |
| MX2024011518A (es) | 2022-03-23 | 2024-09-24 | Synaffix Bv | Conjugados de anticuerpos para el tratamiento de tumores que expresan ptk7. |
| MX2024011519A (es) | 2022-03-23 | 2024-09-24 | Synaffix Bv | Conjugados de anticuerpos para el direccionamiento contra tumores que expresan el antigeno carcinoembrionario. |
| EP4496593A1 (en) | 2022-03-23 | 2025-01-29 | Synaffix B.V. | Antibody-conjugates for targeting of tumours expressing nectin-4 |
| WO2024140933A1 (zh) * | 2022-12-30 | 2024-07-04 | 长春金赛药业有限责任公司 | 喜树碱衍生物、药物组合物及其制备方法和应用 |
| KR20250150111A (ko) * | 2023-02-23 | 2025-10-17 | 프론트라인 바이오파마(항저우) 컴퍼니 리미티드 | 캄프토테신 유도체 및 이의 접합체, 이의 제조 방법 및 의학적 용도 |
| CN121194800A (zh) * | 2023-05-12 | 2025-12-23 | 百奥赛图(北京)医药科技股份有限公司 | 接头化合物和配体-药物缀合物及其制备方法和用途 |
| CN119371430A (zh) * | 2023-07-26 | 2025-01-28 | 上海医药集团股份有限公司 | 喜树碱类小分子及其抗体药物偶联物、制备方法和应用 |
| WO2025167743A1 (zh) * | 2024-02-06 | 2025-08-14 | 四川科伦博泰生物医药股份有限公司 | 抗体药物偶联物及其制备方法和用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US32518A (en) * | 1861-06-11 | Improvement in city railroads | ||
| JPS51288A (ja) * | 1974-06-18 | 1976-01-05 | Tamura Seisakusho Kk | Hanshakyoshinhoshasochi |
| US4399282A (en) | 1979-07-10 | 1983-08-16 | Kabushiki Kaisha Yakult Honsha | Camptothecin derivatives |
| US4399276A (en) * | 1981-01-09 | 1983-08-16 | Kabushiki Kaisha Yakult Honsha | 7-Substituted camptothecin derivatives |
| US4473692A (en) * | 1981-09-04 | 1984-09-25 | Kabushiki Kaisha Yakult Honsha | Camptothecin derivatives and process for preparing same |
| JPS5839685A (ja) * | 1981-09-04 | 1983-03-08 | Yakult Honsha Co Ltd | 新規なカンプトテシン誘導体及びその製造法 |
| JPS58154582A (ja) * | 1982-03-10 | 1983-09-14 | Yakult Honsha Co Ltd | 新規なカンプトテシン誘導体およびその製造法 |
| JPS6019790A (ja) * | 1983-07-14 | 1985-01-31 | Yakult Honsha Co Ltd | 新規なカンプトテシン誘導体 |
| DE3682874D1 (de) * | 1985-10-21 | 1992-01-23 | Daiichi Seiyaku Co | Pyranoindolizinderivate und verfahren zu ihrer herstellung. |
| US4939255A (en) * | 1987-06-24 | 1990-07-03 | Daiichi Pharmaceutical Co., Ltd. | Hexa-cyclic camptothecin derivatives |
| US5004758A (en) * | 1987-12-01 | 1991-04-02 | Smithkline Beecham Corporation | Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells |
| JPH0615547B2 (ja) * | 1988-01-20 | 1994-03-02 | 株式会社ヤクルト本社 | 新規なカンプトテシン誘導体 |
-
1988
- 1988-06-16 US US07/207,718 patent/US4939255A/en not_active Expired - Fee Related
- 1988-06-20 IE IE186088A patent/IE61281B1/en not_active IP Right Cessation
- 1988-06-21 CA CA000569969A patent/CA1304370C/en not_active Expired - Lifetime
- 1988-06-23 EP EP88110044A patent/EP0296597B1/en not_active Expired - Lifetime
- 1988-06-23 ES ES88110044T patent/ES2064329T3/es not_active Expired - Lifetime
- 1988-06-23 NO NO882785A patent/NO167738C/no unknown
- 1988-06-23 AT AT88110044T patent/ATE111913T1/de not_active IP Right Cessation
- 1988-06-23 FI FI883050A patent/FI91872C/fi not_active IP Right Cessation
- 1988-06-23 DE DE3851577T patent/DE3851577T2/de not_active Expired - Fee Related
- 1988-06-23 DK DK344488A patent/DK344488A/da not_active Application Discontinuation
- 1988-06-24 AU AU18349/88A patent/AU610189B2/en not_active Ceased
- 1988-06-24 KR KR1019880007643A patent/KR960002853B1/ko not_active Expired - Fee Related
- 1988-07-22 PH PH37104A patent/PH27557A/en unknown
-
1989
- 1989-12-27 US US07/457,921 patent/US5061795A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| IE881860L (en) | 1988-12-24 |
| NO882785L (no) | 1988-12-27 |
| NO167738B (no) | 1991-08-26 |
| FI883050L (fi) | 1988-12-25 |
| FI91872B (fi) | 1994-05-13 |
| DE3851577T2 (de) | 1995-04-27 |
| US4939255A (en) | 1990-07-03 |
| EP0296597A2 (en) | 1988-12-28 |
| FI91872C (fi) | 1994-08-25 |
| EP0296597B1 (en) | 1994-09-21 |
| ES2064329T3 (es) | 1995-02-01 |
| AU1834988A (en) | 1989-01-05 |
| FI883050A0 (fi) | 1988-06-23 |
| ATE111913T1 (de) | 1994-10-15 |
| PH27557A (en) | 1993-08-18 |
| IE61281B1 (en) | 1994-10-19 |
| NO882785D0 (no) | 1988-06-23 |
| KR960002853B1 (ko) | 1996-02-27 |
| KR890000489A (ko) | 1989-03-15 |
| US5061795A (en) | 1991-10-29 |
| DK344488A (da) | 1989-02-24 |
| DE3851577D1 (de) | 1994-10-27 |
| CA1304370C (en) | 1992-06-30 |
| AU610189B2 (en) | 1991-05-16 |
| NO167738C (no) | 1991-12-04 |
| EP0296597A3 (en) | 1991-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK344488A (da) | Hexacycliske forbindelser | |
| NO920201D0 (no) | Heksacyklisk forbindelse | |
| NO2002009I2 (no) | Tiotropium | |
| IN170909B (da) | ||
| AU577928B2 (en) | Labd-14-en-11-one derivatives | |
| ES525786A0 (es) | Un procedimiento para preparar derivados de pirazolo (3,4-b) piridina | |
| MX9300875A (es) | Procedimiento para la preparacion de compuestos azabiciclicos. | |
| ES2033279T3 (es) | Procedimiento para preparar un compuesto a base de quinolina. | |
| ES2021515A6 (es) | Procedimiento para la preparacion de compuestos derivados de isotiazolo-piridona azetidinil substituidos. | |
| ES2113345T3 (es) | Tratamiento de la disfuncion cardiaca con la ayuda de compuestos 15-ceto-prostaglandina. | |
| MD121C2 (ro) | Procedeu de obţinere a derivaţilor tienopiranului | |
| PT76693A (en) | (-)-15-deoxyspergualin a process for the preparation of the same an intermediate of the same and its use as medicament | |
| HUT46214A (en) | Process for producing medical preparation suitable for treatment of peptic ulcer | |
| NO910911D0 (no) | Fremgangsmaate for fremstilling av oxazolinforbindelser. | |
| FI891866A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten sulfonanilidien valmistamiseksi | |
| NO166617C (no) | Fremgangsmaate for fremstilling av injiserbare oksytetracyklinopploesninger. | |
| GR3002699T3 (en) | Process for stabilising procaterol | |
| PT75881A (en) | Process for preparing 3-methyl-3-(4-acetylaminophenoxy)-2,4-dioxa-benzocyclohexen-1-one having analgesic antiinflammatory and antipiretic activity and of pharmaceutical compositions containing the same | |
| PT87064A (pt) | Process for the preparation of 5-hydroxydiprafenone and its acid addition salts | |
| EP0307226B1 (en) | Process for the preparation of a macrolide compound | |
| ES2039270T3 (es) | Derivados de gamma-l-glutamil-4-nitroanilida y procedimiento para determinar actividad de gamma-gtp utilizandolos. | |
| DK0412464T3 (da) | Butalactin, en fremgangsmåde til dets fremstilling og dets anvendelse som lægemiddel | |
| DE3379224D1 (en) | 3-methoxy-n-methylmorphinane : theophyllinacetic acid (1:2) complex, process for preparing the same and said complex for therapeutical use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHS | Application shelved for other reasons than non-payment |